GADD45B
Aliases:
This biomarker is also known as:- Myeloid differentiation primary response protein MyD118
- growth arrest and DNA damage-inducible protein GADD45 beta
- MYD118
- GADD45BETA
- DKFZP566B133
- Negative growth regulatory protein MyD118
- myeloid differentiation primary response protein MyD118
- growth arrest and DNA-damage-inducible, beta
- GADD45B
- negative growth regulatory protein MyD118
Description…
From NCBI Gene: This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. The genes in this group respond to environmental stresses by mediating activation of the p38/JNK pathway. This activation is mediated via their proteins binding and activating MTK1/MEKK4 kinase, which is an upstream activator of both p38 and JNK MAPKs. The function of these genes or their protein products is involved in the regulation of growth and apoptosis. These genes are regulated by different mechanisms, but they are often coordinately expressed and can function cooperatively in inhibiting cell growth. [provided by RefSeq, Jul 2008]
Datasets
There are no datasets associated with this biomarker.
Attributes
| QA State: | Curated |
|---|---|
| Type: | Gene |
| HGNC Name: | GADD45B |
The following organs have data associated with this biomarker…
Attributes
| Phase: | 1 |
|---|---|
| QA State: | Curated |
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
- History and molecular genetics of Lynch syndrome in family G: a century later.
- Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers.
- Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from 2-methoxyestradiol-induced-mitochondria-dependent apoptosis.